![Susan Wyrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Wyrick
Comptroller/Controller/Auditor bij
SANA BIOTECHNOLOGY, INC.
Vermogen: 684 724 $ op 30-06-2026
Profiel
Ms. Susan D.
Wyrick, CPA, is a Senior Vice President-Finance & Accounting at Sana Biotechnology, Inc. Ms. Wyrick was previously employed as a Vice President & Controller by Juno Therapeutics, Inc. and a Chief Accounting Officer & Vice President-Finance by OncoGenex Pharmaceuticals, Inc. She received her undergraduate degree from the University of Washington.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-03-2026 | 196.196 ( 0,08% ) | 684 724 $ | 30-06-2026 |
Actieve functies van Susan Wyrick
| Bedrijven | Functie | Begin |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 04-10-2024 |
Eerdere bekende functies van Susan Wyrick
| Bedrijven | Functie | Einde |
|---|---|---|
| JUNO THERAPEUTICS INC | Comptroller/Controller/Auditor | 01-10-2018 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Comptroller/Controller/Auditor | 11-06-2014 |
Opleiding van Susan Wyrick
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
